Full-length recombinant Plasmodium falciparum VAR2CSA binds specifically to CSPG and induces potent parasite adhesion-blocking antibodies.
Plasmodium falciparum malaria remains one of the world's leading causes of human suffering and poverty. Each year, the disease takes 1-3 million lives, mainly in sub-Saharan Africa. The adhesion of infected erythrocytes (IEs) to vascular endothelium or placenta is the key event in the pathogene...
Main Authors: | Khunrae, P, Dahlbäck, M, Nielsen, M, Andersen, G, Ditlev, S, Resende, M, Pinto, V, Theander, T, Higgins, M, Salanti, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Several domains from VAR2CSA can induce <it>Plasmodium falciparum </it>adhesion-blocking antibodies
by: Theander Thor G, et al.
Published: (2010-01-01) -
Identification of glycosaminoglycan binding regions in the <it>Plasmodium falciparum </it>encoded placental sequestration ligand, VAR2CSA
by: Theander Thor G, et al.
Published: (2008-06-01) -
Differential induction of functional IgG using the Plasmodium falciparum placental malaria vaccine candidate VAR2CSA.
by: Vera V Pinto, et al.
Published: (2011-03-01) -
Structural comparison of two CSPG-binding DBL domains from the VAR2CSA protein important in malaria during pregnancy.
by: Khunrae, P, et al.
Published: (2009) -
Structural insight into epitopes in the pregnancy-associated malaria protein VAR2CSA.
by: Pernille Andersen, et al.
Published: (2008-02-01)